Donor Egg IVF Services Market Research Report by Type, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Donor Egg IVF Services Market size was estimated at USD 1,884.34 million in 2021 and expected to reach USD 2,067.46 million in 2022, and is projected to grow at a CAGR 9.89% to reach USD 3,319.14 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Donor Egg IVF Services to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Fresh Donor Eggs and Frozen Donor Eggs.

Based on End-user, the market was studied across Fertility Clinics and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Donor Egg IVF Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Donor Egg IVF Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Donor Egg IVF Services Market, including Aevitas Fertility Clinic, Bangkok IVF Center, Bangkok IVF Center (Bangkok Hospital), Beacon CARE Fertility, Bloom Fertility Center, Bourn Hall Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Dominion Fertility, Fertility Associates, Fertility First, Flinders Reproductive Medicine Pty Ltd., Genea Oxford Fertility Limited, IVF Canada, IVF NAMBA Clinic, KL Fertility & Gynaecology Centre, Medfem Fertility Clinic, Merrion Fertility Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Procrea Fertility, Raffles Medical Group, Repromed, SAFE Fertility Center, Sanno Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai United Family Hospital, Sims IVF, Southend Fertility and IVF, The Cape Fertility Clinic, The Montreal Fertility Center, Thomson Medical Pte. Ltd., TMC Fertility Centre, TRIO Fertility, and Virtus Health.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Donor Egg IVF Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Donor Egg IVF Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Donor Egg IVF Services Market?
4. What is the competitive strategic window for opportunities in the Global Donor Egg IVF Services Market?
5. What are the technology trends and regulatory frameworks in the Global Donor Egg IVF Services Market?
6. What is the market share of the leading vendors in the Global Donor Egg IVF Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Donor Egg IVF Services Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing practice of delaying pregnancy among the younger generation
5.1.1.2. Increasing infertility patients due to unhealthy lifestyle
5.1.1.3. Increase in gamete donations
5.1.1.4. High IVF success rates
5.1.2. Restraints
5.1.2.1. Complications related to the IVF treatment
5.1.2.2. Religion or social concern
5.1.3. Opportunities
5.1.3.1. Rising IVF acceptance in urban areas
5.1.3.2. Increasing fertility tourism
5.1.3.3. Rising number of fertility clinics
5.1.4. Challenges
5.1.4.1. Low awareness among people
5.2. Cumulative Impact of COVID-19

6. Donor Egg IVF Services Market, by Type
6.1. Introduction
6.2. Fresh Donor Eggs
6.3. Frozen Donor Eggs

7. Donor Egg IVF Services Market, by End-user
7.1. Introduction
7.2. Fertility Clinics
7.3. Hospitals

8. Americas Donor Egg IVF Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Donor Egg IVF Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Donor Egg IVF Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Aevitas Fertility Clinic
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Bangkok IVF Center
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Bangkok IVF Center (Bangkok Hospital)
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Beacon CARE Fertility
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Bloom Fertility Center
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Bourn Hall Fertility Center
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Chennai Fertility Center
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Cloudnine Fertility
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Damai Service Hospital
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Dominion Fertility
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Fertility Associates
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Fertility First
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Flinders Reproductive Medicine Pty Ltd.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Genea Oxford Fertility Limited
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. IVF Canada
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. IVF NAMBA Clinic
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. KL Fertility & Gynaecology Centre
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Medfem Fertility Clinic
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Merrion Fertility Clinic
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Monash IVF Wesley Hospital Auchenflower
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Morpheus Life Sciences Pvt. Ltd.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Procrea Fertility
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Raffles Medical Group
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Repromed
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services
12.25. SAFE Fertility Center
12.25.1. Business Overview
12.25.2. Key Executives
12.25.3. Product & Services
12.26. Sanno Hospital
12.26.1. Business Overview
12.26.2. Key Executives
12.26.3. Product & Services
12.27. Shanghai Ji Ai Genetics & IVF Institute
12.27.1. Business Overview
12.27.2. Key Executives
12.27.3. Product & Services
12.28. Shanghai United Family Hospital
12.28.1. Business Overview
12.28.2. Key Executives
12.28.3. Product & Services
12.29. Sims IVF
12.29.1. Business Overview
12.29.2. Key Executives
12.29.3. Product & Services
12.30. Southend Fertility and IVF
12.30.1. Business Overview
12.30.2. Key Executives
12.30.3. Product & Services
12.31. The Cape Fertility Clinic
12.31.1. Business Overview
12.31.2. Key Executives
12.31.3. Product & Services
12.32. The Montreal Fertility Center
12.32.1. Business Overview
12.32.2. Key Executives
12.32.3. Product & Services
12.33. Thomson Medical Pte. Ltd.
12.33.1. Business Overview
12.33.2. Key Executives
12.33.3. Product & Services
12.34. TMC Fertility Centre
12.34.1. Business Overview
12.34.2. Key Executives
12.34.3. Product & Services
12.35. TRIO Fertility
12.35.1. Business Overview
12.35.2. Key Executives
12.35.3. Product & Services
12.36. Virtus Health
12.36.1. Business Overview
12.36.2. Key Executives
12.36.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing